Skip to content
Search AI Powered

Latest Stories

#VotePharmacy Manifesto: Pharmacy bodies urge political parties to adopt 6-point plan

#VotePharmacy Manifesto: Pharmacy bodies urge political parties to adopt 6-point plan
Pharmacy leaders advocate for comprehensive reforms to secure the future of community pharmacies amid funding and operational challenges

The Chief Executives of Community Pharmacy England(CPE), the Company Chemists’ Association(CCA), the National Pharmacy Association(NPA), and the Chair of the Royal Pharmaceutical Society’s(RPS) English Pharmacy Board (EPB) have issued an open letter to political parties, urging the adoption of the six-point plan outlined in the #VotePharmacy general election manifesto.

This initiative aims to bolster community pharmacy in the run-up to the next general election.


Launched in March 2024, the #VotePharmacy manifesto serves as a comprehensive guide for the community pharmacy sector.

It aims to help local pharmacy committees (LPCs) and pharmacy owners engage with political parties and candidates.

The open letter highlights the critical role of the 10,500+ community pharmacies in England.

These pharmacies have been pivotal in providing accessible healthcare and medicines to patients.

The recent introduction of the Pharmacy First service underscores the expanding role of pharmacies.

With over 98 per cent of pharmacies participating in this service, more than a million people have already benefited, illustrating the sector's capacity to alleviate pressures on the NHS.

However, the letter points out that the community pharmacy sector is facing a crisis.

Government funding has not kept pace with the increasing demands of the NHS and rising operational costs.

The Health and Social Care Committee has recognised the potential of pharmacies to enhance healthcare access but also noted that the current Community Pharmacy Contractual Framework(CPCF) is outdated and requires a complete overhaul.

The six-point plan detailed in the manifesto includes:

1. Filling the funding gap and committing to a sustainable, long-term funding solution.

2. Supporting and enhancing the community pharmacy workforce.

3. Conducting a thorough review of the medicines supply chain.

4. Rolling out an enhanced Pharmacy First service across England.

5. Empowering community pharmacists with a roadmap for independent prescribing.

6. Making pharmacies central to public health, prevention, and reducing health inequalities.

The pharmacy bodies emphasise that with proper investment, the sector can significantly enhance patient access, alleviate GP workloads, and support the NHS in reducing care backlogs.

They call on all political parties to adopt this six-point plan to ensure a robust future for community pharmacy.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less